2Concepcion AR, Medina JF. Approaches to the pathogenesis of primary biliary cirrhosis through animal models [ J]. Clin Res Hepatol Gastro- enterol, 2011, Sep 8 : ahead of print.
3Jones DE, Al-Rifai A, Frith J, et al. The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Resuhs of a 9 year cohort follow-up ( vo153, pg 911,2010 ) [ J ]. J Hepatol, 2011, 55(3) : 737-737.
4Selmi C, Invernizzi P, Zuin M, et al. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology [J]. Semin Liver Dis, 2005, 25 (3) : 265-280.
8Wesiersk-Gadek J, Penner E, Buttezzati PM, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cinhosis [ J ]. Hepatology, 2006, 43(5) : 1135-1144.
9Efe C, Ozaslan E, Purnak T, et al. Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis [J]. Clin Res Hepatol Gastroenterol, 2012, 36 (2) : 185-188.
10Yasuto T, Fusao I, Shin-ichi F, et al. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid [J]. J Gastroenterol Hepatol, 2011, 26(9) :1395-1401.
